John Hood, CEO, Endeavor BioMedicines discusses partnering with advocacy groups to increase awareness of clinical trials for idiopathic pulmonary fibrosis.

In most cases leftover pathology samples are thrown away Sometimes though they may be used again for other purposes including ...

With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

1 Division of Pulmonary and Critical Care, Department of Internal Medicine, Tannourine Governmental Hospital, Batroun, Lebanon. 2 Division of Pulmonary and Critical Care, Department of Internal ...

with greater amounts of viral proteins co-localized with tangles of phosphorylated tau—one of the hallmarks of Alzheimer's disease pathology—in brain regions especially vulnerable to Alzheimer ...

HOUSTON, January 01, 2025--(BUSINESS WIRE)--Hamershlag Private Capital Management Limited (HPCM), a leading health technology investment firm, has announced a significant venture investment in Patho ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity. This ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window There was "low but improving uptake" of reporting about the ...